A research team led from the University of Malaga (UMA) and the Andalusian Center for Nanomedicine and Biotechnology (BIONAND) identified 4-phenylbutyric acid or 4-PBA as a potential candidate to target what are identified as severe consequences associated with...
UCLA
Category
UCLA-led Study Points to Real-World Evidence COVID-19 Arrived in Los Angeles by Late December 2019
This last December 2019, this writer had a house guest, an old classmate from University of California Los Angeles (UCLA). At least once a year this friend typically visits, often remaining for at least a week if not two. This past December was different from past...
UCLA Researchers Receive COVID-19 Grants as California Stem Cell Agency Rewards Bruin R&D Excellence
Two University of California Los Angeles (UCLA) Scientists have received separate State of California grants for their potential COVID-19 treatment and vaccine booster. Issued by The California Institute for Regenerative Medicine (CIRM, the awards go to associate...
Randomized Controlled Trials vs. Real-World Studies in COPD Pharmacotherapy: Any Preferences?
A study led by Donald P. Tashkin, MD with UCLA’s David Geffen School of Medicine, and colleagues from UC Irvine and the Clinical Research Institute of Southern Oregon looked into analytic epidemiological studies running the gamut from noninterventional observational...
UCLA Jonsson Center PI Leads Study to Suppress Male Hormone in Attempt to Reduce COVID-19 Severity
University of Los Angeles, California (UCLA) researchers are pursuing COVID-19 via a commonly used method to treat men with prostate cancer in an effort to help drive improved clinical outcomes for individuals afflicted with SARS-CoV-2, the virus behind COVID-19....
University of Iowa Carver College of Medicine Receives $3.7m with UCLA to Study SARS-CoV-2 Transmission in Emergency Dept
The Centers for Disease Control and Prevention awarded the University of Iowa Carver College of Medicine a joint $3.7 million grant to study how to reduce emergency health care workers’ risk of contracting COVID-19 while in the process of treating patients infected...
Southern California-based CSUN Alumni & Clinical Trial Expert Cautiously Optimistic about COVID-19 & Ramp up of Clinical Trials
Epidemiologist and Cal State University Northridge (CSUN) alumna Dr. Laurie Shaker-Irwin recently shed some light on current COVID-19 clinical trials. Ms. Shaker-Irwin is a leader in the field of epidemiology with an emphasis on regenerative medicine and stem cell...
NIH Study Reveals COVID-19 Far more Contagious than Previously Assumed
A new COVID-19-based study led by the National Institutes of Health (NIH), CDC, UCLA and Princeton University find that the novel coronavirus can persist in the air and on surfaces for hours, if not days—highlighting just how contagious this virus may be. As it turns...
SEQUOIA Study Reveals No Clinical Benefit Adding Pegilodecakin and FOLFOX for Pancreatic Cancer Patients
Joel Randolph Hecht, MD, David Geffen School of Medicine, University of California Los Angeles (UCLA), reports on the Oncology Learning Network that, unfortunately, the findings from the SEQUOIA clinical trial of GEM-refractory pancreatic adenocarcinoma reveal no...
UCLA Study Reveals Inhibition of Gene Helps Overcome Resistance to Immunotherapy
A UCLA Jonsson Comprehensive Cancer Center study reveals inhibition of gene helps overcome resistance to immunotherapy leading the team to believe that this could represent a new strategy for patients with advanced cancers that fail to respond to current cancer...
University of Washington Study Reveals AI Capable of Out-Performing Human Doctors for Some Breast Cancer Diagnosis
The University of Washington and University of California, Los Angeles (UCLA) researchers have developed an artificial intelligence (AI) system that may help pathologists improve the accuracy of biopsy reviewed as well as lead to better detection and diagnosis of...
Yvonne Chen of UCLA Receives $1.25M to Pursue A Better CAR-T Cell as Part of Immunotherapy Research
Yvonne Chen, assistant professor of chemical and biomolecular engineering at the UCLA Samueli School of Engineering, has received a $1.25 million grant from the Cancer Research Institute to support her studies of immunotherapies for cancer. Professor Chen is a member...
FocalNet, AI System from UCLA as Accurate as a Radiologist
UCLA Researchers introduce results from their new artificial intelligence (AI) system and find that it performs as well as experienced radiologists in detecting prostate cancer. Back in the Spring UCLA researchers developed an AI system to help radiologists improve...
UCLA Adopts Microsoft AI Tool to Advance Precision Medicine
UCLA Health is deploying cloud computing using the Microsoft Azure cloud. Leveraging their artificial intelligence (AI) algorithms, they seek to enable synthesize vast amounts of clinical data and increase collaboration among researchers. Follow the link to HealthIT...
UCLA Awarded $4.6 Million for Stem Cell Trial for Sarcoma Treatment
Researchers at the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research secured $4.6 million in grant money from the California Institute for Regenerative Medicine (CIRM). The grant will contribute to support a phase I clinical trial of a...
The California Rehabilitation Institute Appoints New Director of Research
California Rehabilitation Institute, a three-way partnership among UCLA Health, Cedars-Sinai and Select Medical, appointed Steven C. Cramer, M.D., Director of Rehabilitation Research. In his new post, Dr. Cramer will continue his multifaceted research in stroke and...
Pathbreaking Gene Therapy Successful with X-Linked MTM in 9 Boys
Researchers have used a pathbreaking new gene therapy that had had incredible results in nine boys born with myotubular myopathy (MTM), a rare disease that causes extreme muscle weakness often from birth. Since the gene therapy treatment, all of the boys have better...
UCLA Receives $20 Million Grant to Fund Biomedical Research & Medical Center Upgrades
University of Southern California, Los Angeles reports the institution will receive $20 million to fund competitive biomedical-research grants. They also received renovation funds for the UCLA Medical Plaza, an outpatient care center in Los Angeles.
UCLA Investigator Receives Grant to Study Immunotherapy for Brain Tumors
As reported in Healio, UCLA professor Robert M. Prins, PhD, has received a $750,000 grant from the Brain Tumor Funders’ Collaborative to support his research of immunotherapies for brain therapies. Prins is a professor of neurosurgery and molecular and medical...
UCLA-Led Research Team Pinpoints Genes Tied to Dementia
As reported in Science Daily, a research team has identified genetic processes involved in the neurodegeneration that occurs in dementia—an important step on the path toward developing therapies that could slow or halt the course of the disease. Lead...